# New Animal Drugs; Amprolium; Bambermycins; Ceftiofur; Deslorelin; Florfenicol; Florfenicol and Flunixin; Paclitaxel; Phenylbutazone; Pimobendan; Salinomycin; Tilmicosin; Tiludronate; Change of Sponsor
> **Food and Drug Administration** · Final rule. · Published 2014-04-01 · Effective 2014-04-01 · 79 FR 18156
## Document
- **Document number:** 2014-07220
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 79 FR 18156
- **CFR reference:** 21 CFR 510
- **Publication date:** 2014-04-01
- **Effective date:** 2014-04-01
- **HHS docket:** Docket No. FDA-2013-N-0002
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval actions for new animal drug applications (NADAs) and abbreviated new animal drug applications (ANADAs) during January and February 2014. FDA is also informing the public of the availability of summaries of the basis of approval and of environmental review documents, where applicable. The animal drug regulations are also being amended to reflect previous approval of revised food safety warnings. This is being done to improve the accuracy of the regulations. The animal drug regulations are also being amended to reflect a change of sponsorship of an NADA and a change to a sponsor's address.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2014/04/01/2014-07220/new-animal-drugs-amprolium-bambermycins-ceftiofur-deslorelin-florfenicol-florfenicol-and-flunixin)
---
*AI Analytics · CC0 1.0*